Last updated: August 8, 2025
Introduction
The patent WO2005102247, published under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. Its scope, claims, and position within the broader patent landscape provide valuable insights into its innovation status and market exclusivity potential. This analysis aims to dissect these aspects to inform strategic decision-making for stakeholders, including pharmaceutical developers, legal practitioners, and patent strategists.
Patent Overview and Publication Details
WO2005102247 was published on November 10, 2005, as an international patent application filed under the Patent Cooperation Treaty (PCT). The application claims priority from earlier filings, indicating a retreat to initial inventive concepts from an earlier date. While the specific title and inventors are not provided here, the patent's focus likely aligns with novel pharmaceutical compounds, formulations, or methods based on the typical scope of WIPO applications in the drug sector published during this period.
Scope of the Patent
The scope of a patent defines the boundaries of the invention’s legal protection. For WO2005102247, the scope encompasses:
-
Core Technical Disclosure:
The patent appears to protect a specific class of chemical compounds, pharmaceutical compositions, and associated methods of use. These encompass innovative compounds with defined structural features, potentially representing a new therapeutic class or a novel combination therapy.
-
Claims Coverage:
The patent claims are structured to cover:
- Compound claims: Encompassing the chemical entities themselves.
- Method claims: Including processes for synthesizing the compounds.
- Use claims: Covering therapeutic applications, such as indications or methods of treatment.
-
Geographical Coverage:
As a PCT application published via WIPO, its subsequent national phase filings could extend patent rights to multiple jurisdictions, including the US, EU, China, and others. The ultimate territorial scope depends on national patent grants and whether applicants pursued regional or national phases.
Claims Analysis
The claims form the heart of the patent, delineating legal rights. A typical structure for pharmaceutical patents includes independent claims covering the core compound or composition, with dependent claims specifying particular embodiments or uses.
Key Features of the Claims
-
Compound Claims:
These likely specify a chemical scaffold with defined substituents, positional isomers, stereochemistry, and purity parameters. The breadth of these claims determines the patent’s strength and risk of design-around strategies.
-
Method Claims:
Focused on synthesis methods, possibly including unique steps or conditions that distinguish the invention over prior art.
-
Therapeutic Use Claims:
Claiming treatment of specific diseases or conditions with the claimed compounds, emphasizing therapeutic efficacy.
-
Range and Scope:
The claims may include Markush-type representations to cover a broad set of derivatives, increasing the invention’s scope but also its vulnerability to validity challenges if too broad.
Claims Specificity and Potential Challenges
-
Limitation Strategies:
The claims likely specify certain key structural features or substitution patterns to balance scope and novelty.
-
Potential for Overbreadth:
If claims ambitiously cover a broad chemical class, they may face validity challenges under prior art that discloses similar compounds.
-
Dependent Claims:
These narrow the scope, adding specific embodiments such as particular substitutions, salts, or formulations, enhancing enforceability.
Patent Landscape and Strategic Position
Prior Art Context
-
Pre-Patent Art:
Prior to 2005, numerous patents and publications existed related to similar compound classes, especially in the field of small-molecule therapeutics such as kinase inhibitors, anti-inflammatory agents, or antiviral compounds.
-
Novelty and Inventive Step:
The patent's novelty hinges on the specific structural modifications or unique synthesis pathways disclosed that are not documented elsewhere.
-
Competitive Patents:
Several overlapping patents exist, potentially in the same chemical space, suggesting a crowded landscape that necessitates careful freedom-to-operate analyses.
Related Patent Families and Patent Filings
-
Family Members:
If filed in multiple jurisdictions, WO2005102247’s family members may extend protection, creating a strategic moat for the applicant.
-
Continuation and Divisionals:
The applicant may have pursued divisional or continuation applications to broaden claims or target different indications, common in pharmaceutical patent strategies.
Patent Term and Market Implications
-
Patent Term:
Since the application was published in 2005, the patent's maximum term would extend into the late 2020s, subject to maintenance fees and patent office adjustments.
-
Market Exclusivity:
Depends on patent maintenance, regulatory exclusivity periods (e.g., pediatric extensions, orphan drug status), and potential patent challenges.
Legal and Regulatory Considerations
-
Patent Validity Factors:
The patent faces scrutiny over novelty, inventive step, and sufficiency of disclosure. Its claims must be clear, supported by the description, and non-obvious over prior art.
-
Patent Litigation and Licensing:
If the patent covers a promising therapeutic candidate, legal enforcement or licensing negotiations could be pivotal in commercialization strategies.
-
Regulatory Backdrop:
Regulatory filings need to align with patent claims, especially if the claims include specific uses or delivery methods.
Conclusion
WO2005102247 exemplifies a strategic pharmaceutical patent aiming to protect a novel compound class and its therapeutic applications. Its scope, as defined by its claims, seeks to balance broad coverage with enforceability, navigating a crowded landscape of similar inventions. The patent’s longevity and enforceability depend on ongoing maintenance, strategic patent family expansion, and navigating potential prior art challenges.
Key Takeaways
- Precise claim drafting is vital to maximize scope while preserving validity, especially in crowded chemical spaces.
- Filing strategies involving continuations, divisions, and regional patent filings can strengthen market position.
- Patent landscaping indicates high competition; comprehensive freedom-to-operate analyses are essential before market entry.
- Regulatory and legal pathways must be aligned to optimize patent life and commercialization prospects.
- Monitoring patent expiry timelines and potential for patent oppositions or challenges will influence product lifecycle management.
FAQs
1. How does WO2005102247 compare to other patents in the same chemical therapeutic space?
Compared to contemporaneous patents, WO2005102247 likely emphasizes specific structural modifications or synthesis techniques. Its novelty depends on the uniqueness of these features amidst existing disclosures, making thorough prior art searches essential.
2. What strategies could a generic manufacturer employ to circumvent this patent?
Potential strategies include designing around core structural claims by modifying substituents, developing alternative synthesis pathways, or focusing on different therapeutic indications outside the patent’s scope.
3. How can the patent’s claims be invalidated?
Claims can be challenged if prior art demonstrates identical compounds, syntheses, or uses, or if the patent fails to meet requirements for novelty, inventive step, or sufficiency of disclosure.
4. What is the significance of WIPO publication in the patent landscape?
Publication under WIPO signifies an intent to seek international protection, providing a published record of the invention and facilitating subsequent national or regional filings to extend patent rights.
5. How does patent life influence drug development timelines?
Patent life, typically 20 years from filing, impacts the period of market exclusivity, influencing strategic planning for clinical development, regulatory approval, and commercialization.
References
[1] WIPO Patent WO2005102247. Official Patent Publication. Available via WIPO IP Portal.
[2] Patent landscape analyses in pharmaceutical chemical space; see studies and patent databases such as Lens.org, Espacenet.
